ADAMTSL5 is an epigenetically activated gene underlying tumorigenesis and drug resistance in hepatocellular carcinoma
María Arechederra, Sehrish Khan Bazai, Ahmed Abdouni, Celia Sequera, Timothy J. Mead, Sylvie Richelme, Fabrice Daian, Stéphane Audebert, Rosanna Dono, Anthony Lozano, Damien Grégoire, Urszula Hibner, Daniela Allende, Suneel Apte, Flavio Maina
Topics & Concepts
Hepatocellular carcinomaCarcinogenesisCancer researchGeneDrug resistanceBiologyMedicineGeneticsEpigenetics and DNA MethylationAngiogenesis and VEGF in CancerTGF-β signaling in diseases